Neuroblastoma trials in Iran
1 trial · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleSafety and Efficacy of Systemic Allogenic NK Cells in R/R Neuroblastoma
- Where
- Tehran
- Age
- 2 years to 16 years
- People
- 10
- Run by
- Marzieh Ebrahimi
See details and how to joinNCT06674265